ArticleOncoTargets and therapy2014

ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression.

Kai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.